Abstract
An evaluation into the underlying cause of neutropenia is important, as this may predict clinical severity and guide anticipatory guidance for families. A thorough medical history and physical examination can often narrow the differential in a child with neutropenia, and laboratory testing is typically reserved for those with a more severe or atypical presentation. Neutrophil autoantibodies remain difficult to detect with current methods and require a combination of agglutination and immunofluorescence testing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178(3):351–63.
Afzal W, Owlia MB, Hasni S. Autoimmune neutropenia updates: etiology, pathology and treatment. South Med J. 2017;110(4):300–7.
Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181–6.
Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther. 2005;7(50):208–14.
Newburger PE. Autoimmune and other acquired neutropenias. Hematol Am Soc Hematol Educ Prog. 2016;2016(1):38–42.
Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med. 1991;80:605–12.
Starkebaum G, Arend WP. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. J Clin Invest. 1979;64:902–12.
Dale DC, Welte K. Cyclic and chronic neutropenia. Cancer Treat Res. 2011;157:97–108.
Farrugia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015;6(1):15–24.
Stroncek D. Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation. Vox Sang. 2004;87(Suppl 2):101–4.
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010;150:196–9.
Andres E, Zimmer J, Affenberger S. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med. 2006;17:529–35.
Bruin MCA, Borne AE, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood. 1999;94(5):1797–802.
Boxer LA, Greenberg MS, Boxer GJ, Stossel TP. Autoimmune neutropenia. N Engl J Med. 1975;293:748–53.
Hadley AG, Holburn AM, Bunch C, Chapel H. Anti-granulocyte opsonic activity and autoimmune neutropenia. Br J Haematol. 1986;63(3):581–9.
Simpson DM, Ross R. Effects of heterologous anti-neutrophil serum in guinea pigs. Hematologic and ultrastructural observations. Am J Pathol. 1971;65:79–102.
Bux J. Molecular Nature of Antigens implicated in immune neutropenias. International Journal Hematology. 2002;76 Suppl 1:399–403.
Bux J, Chapman J. Report on the second international granulocyte serology workshop. Transfusion. 1997;37(9):997–83.
Farrugia P. Immune neutropenias of infancy and childhood. World J Pediatr. 2016;12(2):142–8.
Heinzl MW, Schonbacker M, Dauber E, Panzer S, Mayr WR, Körmöczi GF. Detection of granulocyte-reactive antibodies: a comparison of different methods. Vox Sang. 2015;108:287–93.
Moritz E, Norcia A, Cardone J, Kuwano ST, Chiba AK, Yamamoto M, et al. Human neutrophil alloantigens systems. An Acad Bras Cienc. 2009;81(3):559–69.
Bux J. Human neutrophil alloantigens. Vox Sang. 2008;94:277–85.
Muschter S, Berthold T, Greinacher A. Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol. 2011;18:452–60.
Dungerwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol. 2007;86(3):191–7.
Fioredda F, Calvillo M, Bananomi S, Coliva T, Tucci F, Farruggia P, et al. Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the neutropenia committee of the marrow failure syndrome group of the AIEOP. Am J Hematol. 2012;87(2):238–43.
Fioredda F, Calvillo M, Burlando O, Riccardi F, Caviglia I, Tucci F, et al. Infectious complications in children with severe congenital autoimmune or idiopathic neutropenia: a retrospective study from the Italian neutropenia registry. Pediatr Infect Dis J. 2013;32(4):410–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Chang, A.K. (2018). Evaluation and Management of Autoimmune Neutropenia. In: Despotovic, J. (eds) Immune Hematology. Springer, Cham. https://doi.org/10.1007/978-3-319-73269-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-73269-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73268-8
Online ISBN: 978-3-319-73269-5
eBook Packages: MedicineMedicine (R0)